XML 92 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Jan. 26, 2014
Jan. 27, 2013
Jan. 29, 2012
Cash flows from operating activities:      
Net (loss) income $ (164,466) $ 41,939 $ 89,087
Adjustments to reconcile net (loss) income to net cash provided by operating activities, net of effects of acquisitions:      
Depreciation, amortization and impairments 94,073 49,192 21,013
Goodwill impairment 116,686 0 0
Effect of acquisition fair value adjustments 2,529 37,693 0
Accretion of deferred financing costs and debt discount 1,509 2,545 0
Write-off of deferred financing costs and debt discount 7,093 0 0
Deferred income taxes 29,987 (47,623) (2,023)
Stock-based compensation 24,589 24,528 24,020
Excess tax benefits on stock based compensation (4,220) 0 (2,279)
(Gain) loss on disposition of property, plant and equipment (28) 85 1,022
Changes in assets and liabilities:      
Accounts receivable, net 2,827 (5,002) 966
Inventories 12,238 (4,251) 676
Prepaid expenses and other assets 623 5,971 (7,068)
Accounts payable (11,294) 4,453 (3,354)
Accrued liabilities (2,739) (10,410) (26,017)
Deferred revenue 3,401 (1,112) (1,167)
Income taxes payable and prepaid taxes 1,825 (1,120) 4,962
Other liabilities 3,348 5,080 (6)
Net cash provided by operating activities 117,981 101,968 99,832
Cash flows from investing activities:      
Purchases of available-for-sale investments (1,050) (24,744) (93,330)
Proceeds from sales and maturities of available-for-sale investments 10,249 112,466 131,748
Proceeds from sales of property, plant and equipment 57 0 46
Purchase of property, plant and equipment (37,161) (23,266) (21,564)
Purchase of intangible assets (3,533) (1,251) (3,000)
Purchase of cost method investment (2,500) (2,500) 0
Acquisitions, net of cash acquired 0 (491,717) 0
Net cash (used in) provided by investing activities (33,938) (431,012) 13,900
Cash flows from financing activities:      
Proceeds from debt issuance, net of discount 327,344 347,000 0
Deferred financing cost (2,980) (8,962) 0
Payment for interest rate cap 0 (1,100) 0
Excess tax benefits on stock based compensation 4,220 0 2,279
Proceeds from exercises of stock options 5,876 12,855 42,661
Repurchase of outstanding common stock (30,000) (7,769) (50,665)
Payment of long term debt (368,501) (16,875) 0
Net cash (used in) provided by financing activities (64,041) 325,149 (5,725)
Effect of exchange rate increase (decrease) on cash and cash equivalents 0 65 (4)
Net increase (decrease) in cash and cash equivalents 20,002 (3,830) 108,003
Cash and cash equivalents at beginning of period 223,192 227,022 119,019
Cash and cash equivalents at end of period 243,194 223,192 227,022
Supplemental disclosure of cash flow information      
Income taxes paid 7,227 5,029 4,059
Interest paid $ 8,727 $ 10,556 $ 0